Corporate Banner
Satellite Banner
Technology
Networks
Scientific Communities
 
Become a Member | Sign in
Home>Events>This Event
  Events - March 2012


Adaptive Designs in Clinical Drug Development

26 Mar 2012 - 27 Mar 2012 - London, UK



Bookmark and Share


‘Buying in’ to adaptive design trials: strategies and methods for implementing successful adaptive design studies Monday 26th & Tuesday 27th March 2012, Grange Holborn, London
SMi are proud to present the 6th Annual Adaptive Designs in Clinical Drug Development conference, following on from SMi’s previous highly successful Adaptive Designs events and offers the opportunity to keep up-to-date with the latest challenges and solutions essential for successful and cost-effective adaptive clinical trials.
In recent years, the use of adaptive design in clinical trials has been considered an efficient and optimal way of designing clinical trials.  Adaptive design has gradually evolved from a novel idea into a standard norm in the pharmaceutical industry. This new clinical paradigm could change the way traditional clinical trials, with their restrictive guidance, are run today.
With more flexibility, faster development timelines and significant monetary savings, an adaptive design trial is the way forward.
The conference will address adaptive clinical trials for rare disease medicine development. The agenda will not only tackle issues surrounding effective management of your adaptive design in clinical trials but the increasing use of Bayesian modelling and using adaptive designs in early clinical trials. As adaptive designs are recently gradually evolving from a novel idea into a standard norm in the pharmaceuticals industry, industry leaders are asking themselves whether to adapt or not to adapt.

Key Reasons to attend Adaptive Designs in Clinical Drug Development;
•    Learn how to maximise the benefits of an adaptive design through effective management
•    Develop your knowledge of the adaptive designs. From start to end, it is important to know everything about adaptive clinical trials to gain maximum advantage.
•    Understand the challenges of the high-density biomarker adaptive trial.
•    Discover what the future holds in this rapidly evolving market and the impact of new regulation and technology.
•    Improve your clinical trials in early phases to reduce costs and time.
•    Evolve your understanding of current technologies to protect trial integrity, reduce operational bias and build regulatory confidence.
•    Network with key industry professionals
Visit the website to register: http://www.smi-online.co.uk/2012adaptivedesigns9.asp
Alternatively or contact Shilan Chandi on: +44 (0)20 7827 6738 e-mail: schandi@smi-online.co.uk



Further information
Scientific News
Liquid Biopsies: Miracle Diagnostic or Next New Fad?
Thanks to the development of highly specific gene-amplification and sequencing technologies liquid biopsies access more biomarkers relevant to more cancers than ever before.
Connectome Map More Than Doubles Human Cortex’s Known Regions
Researchers at NIH have developed software that automatically detects the “fingerprint” of each of these areas in an individual’s brain scans.
Discovered Through ‘Big Data’ Analysis
Researchers at the SBP have identified over 100 new genetic regions that affect the immune response to cancer.
Human Stem Cells to Rapidly Generate Bone, Heart Muscle
A new study shows that combining positive and negative signals can quickly and efficiently steer stem cells down complex developmental pathways to become specialized tissues that could be used in the clinic.
New Mechanism of Tuberculosis Infection
Researchers at UTSW Medical Center have identified a new way that tuberculosis bacteria get into the body, revealing a potential therapeutic angle to explore.
New Therapeutic Targets For Small Cell Lung Cancer Identified
Researchers at UTSW Medical Center have identified a protein termed ASCL1 that is essential to the development of small cell lung cancer and that, when deleted in the lungs of mice, prevents the cancer from forming.
Eliminating Doubt in Criminal Investigations
New ASU certificate to help curb error, misunderstanding in the quest for justice.
Determination of 13 Organic Toxicants in Human Blood
Researchers have utilised liquid-liquid extraction coupling HPLC-MS/MS to identify and quantify organic toxicants in human blood.
A Novel Cell Culture Model For Forensic Biology Experiments
Researchers have developed a new cell culture model which provides an efficient research tool in forensic biology.
Rhino DNA Bank Aids Anti-Poaching Fight
At the University of Pretoria's Veterinary Genetics Laboratory (VGL) at Onderstepoort, Dr Cindy Harper and her team have developed a ground-breaking technique to collect and catalogue DNA from rhinos and rhino horns.
Scroll Up
Scroll Down
Skyscraper Banner

Skyscraper Banner
Go to LabTube
Go to eposters
 
Access to the latest scientific news
Exclusive articles
Upload and share your posters on ePosters
Latest presentations and webinars
View a library of 1,800+ scientific and medical posters
3,200+ scientific and medical posters
A library of 2,500+ scientific videos on LabTube
4,800+ scientific videos
Close
Premium CrownJOIN TECHNOLOGY NETWORKS PREMIUM FOR FREE!